HOME
OUR FOCUS
DELIVERING THE PROMISE
PIPELINE
ABOUT US
More
Alexis Bio designs and manufactures innovative, live biotherapeutic solutions that are delivering on the promise
of regenerative medicine.
by Alexis Bio
realNERVE
™
realTISSUE
YEAR
First FDA Pre-IND for Live Biotherapeutic Xenogeneic Nerve Transplant
First Live Biotherapeutic Xenotransplant FDA IND Cleared for Human Clinical Trials
realSKIN® completes FDA Phase I/II (EOP)
realSKIN® designated as a Regenerative Medicine Advanced Therapy (RMAT)
First Human Patient Treated with Live Biotherapeutic Xenotransplant in US FDA Clinical Trial
First Live Biotherapeutic Xenotransplant to Receive FDA Orphan Drug Designation
Learn about our company’s journey
